Canaccord Genuity Upgrades Sarepta Therapeutics To Buy By: Benzinga via Benzinga May 20, 2015 at 08:53 AM EDT Canaccord Genuity upgraded Sarepta Therapeutics Inc (NASDAQ: SRPT) from Hold to Buy. The price target for Sarepta Therapeutics ... Read More >> Related Stocks: Sarepta Therapeutics